AMERICAN JOURNAL OF PREVENTIVE MEDICINE is a premier publication in the fields of Epidemiology and Public Health, published by Elsevier Science Inc. With a commendable impact factor and ranking within the top quartile for both Epidemiology and Public Health categories, this journal serves as a vital source of cutting-edge research, reviews, and critical insights aimed at promoting health and preventing disease. Since its inception in 1985, the journal has been dedicated to disseminating high-quality articles that inform health policy, improve clinical practices, and enhance community health initiatives. It is readily available to researchers and professionals committed to advancing their knowledge and practice, ensuring the continued evolution of preventive medicine. The journal's reach and influence, underscored by its impressive rankings, position it as an essential resource for those looking to make a meaningful impact in the world of preventive health.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, published by the esteemed BMJ PUBLISHING GROUP, stands as a leading journal in the fields of Epidemiology and Public Health. With an impressive impact factor and ranking in the Q1 quartile for both Epidemiology and Public Health categories as of 2023, it significantly contributes to the dissemination of critical research that shapes public health policies and practices globally. The journal has been a vital resource since 1978, continuously providing an academic platform for the latest advancements and discussions pertinent to community health, environmental concerns, and epidemiological studies. Researchers, professionals, and students alike depend on this influential publication for rigorous peer-reviewed articles, thereby enhancing its reputation as one of the top journals in the field. Despite the absence of Open Access options, the journal's scholarly contributions are evident, making it indispensable for anyone engaged in public health and epidemiological research.

Journal of Preventive Medicine & Public Health is a premier peer-reviewed open-access journal published by the Korean Society for Preventive Medicine, dedicated to advancing the fields of preventive medicine and public health. Established in 1968, this journal has carved out a significant niche in the academic community, reflected in its prestigious Q1 ranking in both Medicine (miscellaneous) and Public Health, Environmental, and Occupational Health as of 2023. With a focus on disseminating high-quality research, the journal serves as an essential platform for researchers, professionals, and students to share innovative findings and discuss contemporary challenges in health prevention strategies. The journal maintains a strong commitment to accessibility, offering open access to its content since inception, ensuring that critical research is readily available to the global community. The Journal of Preventive Medicine & Public Health not only contributes to the scientific discourse but also plays a pivotal role in shaping public health policies, making it an invaluable resource for anyone invested in the health sciences.

The American Journal of Public Health, published by the American Public Health Association, stands as a cornerstone in the field of public health and epidemiology since its inception in 1949. With its rigorous peer-review process and a robust commitment to advancing knowledge and research practices, this journal holds a prestigious position in the academic community, as reflected in its 2023 Scopus ranking, where it is placed in the top percentile (93rd) within the categories of Public Health and Environmental and Occupational Health. The journal's focus encompasses a broad spectrum of public health topics, making it essential reading for researchers, practitioners, and students dedicated to improving population health. Subscribers can access invaluable insights through its collection of innovative studies and reviews, thereby reinforcing the journal's role in shaping public health policy and practice. By bridging research and real-world application, the American Journal of Public Health remains a vital resource for those engaged in the quest to improve health outcomes across diverse communities.

Preventing Chronic Disease (ISSN: 1545-1151, E-ISSN: 1545-1151) is a premier open-access journal published by the CENTERS FOR DISEASE CONTROL & PREVENTION in the United States. Since its inception in 2004, this journal has played a vital role in disseminating research focused on the prevention of chronic diseases, offering insights into innovative public health strategies and policies. With a strong commitment to advancing health knowledge, it has achieved a notable impact factor that reinforces its significance—ranking in the Q1 category for both Health Policy and Public Health, Environmental, and Occupational Health as of 2023. With Scopus rankings placing it in the top 13% and 16% in its respective categories, Preventing Chronic Disease serves as a crucial platform for researchers, professionals, and students dedicated to combating chronic conditions. The journal's open-access model ensures that its valuable findings are accessible to a wide audience, fostering collaboration and innovation in public health research and practice.

Health Promotion and Chronic Disease Prevention in Canada - Research Policy and Practice is a leading open-access journal published by the Public Health Agency Canada. This journal, indexed with the ISSN 2368-738X, is dedicated to advancing the field of health promotion while addressing chronic disease prevention in the Canadian context. Since its inception in 2008, it has gained a robust reputation, evidenced by its ranking in the second quartile (Q2) across multiple categories including Epidemiology, Health Policy, and Public Health, Environmental and Occupational Health. With its emphasis on research and policy implications, the journal serves as a critical resource for researchers, healthcare professionals, and students alike, aiming to promote evidence-based practices and driving discussions that shape public health policies. The journal is particularly noted for its triangulation of research findings into actionable strategies, making it relevant for both academic inquiry and practical application. Whether you are seeking to enhance your knowledge or contribute to the discourse on chronic disease prevention, this journal offers a platform for sharing impactful research and innovative ideas.

BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.

The Lancet Public Health is a leading journal in the field of public health, published by Elsevier since 2016. With its prominent Q1 quartile ranking in Public Health, Environmental and Occupational Health according to Scopus for 2023, and an impressive percentile ranking of 99th, the journal has established itself as a vital resource for researchers, professionals, and students committed to advancing public health knowledge and practices. Operating under an Open Access model, this journal ensures that groundbreaking research is readily accessible to all, promoting global collaboration and knowledge sharing. The scope of The Lancet Public Health encompasses diverse aspects of health, including the social determinants of health, epidemiology, health policy, and preventive medicine, making it a cornerstone for addressing contemporary public health challenges. Located in the heart of the United Kingdom, it aims to influence health policies and practices worldwide, showcasing transformative research and fostering vibrant discussions within the field.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.